Cytosorbents Corp
CTSO
47 hedge funds and large institutions have $6.04M invested in Cytosorbents Corp in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 8 closing their positions.
0.55% less ownership
Funds ownership: 26.23% → 25.68% (-0.55%)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
2% less funds holding
Funds holding: 48 → 47 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
36% less capital inflows, than outflows
Capital inflows: $316K | Capital outflows: $496K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$151K |
| 2 |
Virtu Financial
New York
|
+$37.8K |
| 3 |
Jane Street
New York
|
+$27.6K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$18K |
| 5 |
LPL Financial
San Diego,
California
|
+$14.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skylands Capital
Milwaukee,
Wisconsin
|
-$262K |
| 2 |
BlackRock
New York
|
-$82.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$55.6K |
| 4 |
Waverly Advisors
Birmingham,
Alabama
|
-$31.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
CTSO Hedge Fund Activity: Q2 2026 in Review
47 of the 8,365 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2026, worth a combined $6.04M — down 35% from $9.32M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CTSO and 7 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 11 added.
The largest buyer was Neuberger Berman Group, adding an estimated $151K. The largest seller was Skylands Capital, cutting an estimated $262K.
- 47 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2026, down from 48 in Q1 2026.
- Funds reported $6.04M of Cytosorbents Corp stock for Q2 2026, down 35% quarter-over-quarter.
- 7 funds opened new Cytosorbents Corp positions in Q2 2026 and 8 closed out, a net change of -1 holder.
- The largest Cytosorbents Corp buyer in Q2 2026 was Neuberger Berman Group, an estimated $151K added.
- The largest Cytosorbents Corp seller in Q2 2026 was Skylands Capital, an estimated $262K sold.
Based on aggregated 13F filings for Q2 2026.